SEC Form 4 · accession 0001179110-16-022919
ACCELERON PHARMA INC · XLRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven D Ertel
Officer — EVP & Chief Operating Officer
Period of report
Apr 7, 2016
Accepted (ET)
Apr 8, 2016 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 7, 2016 | M | 3,942 | $5.28 | A | 131,098 | D | |
| Common Stock | Apr 7, 2016 | M | 12,500 | $7.12 | A | 143,598 | D | |
| Common Stock | Apr 7, 2016 | M | 2,344 | $5.08 | A | 145,942 | D | |
| Common Stock | Apr 7, 2016 | M | 13,484 | $3.88 | A | 159,426 | D | |
| Common Stock | Apr 7, 2016 | S | 32,270 | $32.00 | D | 127,156 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF2 | $5.28 | Apr 7, 2016 | M | 3,942 | D | — | Dec 16, 2021 | Common Stock | 3,942 | 28,365 | D |
| Option to Purchase Common StockF2 | $7.12 | Apr 7, 2016 | M | 12,500 | D | — | Dec 12, 2022 | Common Stock | 12,500 | 12,500 | D |
| Option to Purchase Common StockF2 | $5.08 | Apr 7, 2016 | M | 2,344 | D | — | Mar 27, 2018 | Common Stock | 2,344 | 0 | D |
| Option to Purchase Common StockF2 | $3.88 | Apr 7, 2016 | M | 13,484 | D | — | Dec 2, 2020 | Common Stock | 13,484 | 10,209 | D |
Explanation of responses
- F1The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The options of registrant's common stock vest in equal quarterly installments over the first four years after the grant.